世界の止血剤市場：分析、企業プロファイル、規模、シェア、成長率、動向、予測

当レポートでは、世界の止血剤市場について調査分析し、市場概要、セグメント別の市場分析、地域別の市場分析、競合情勢、主要企業など、体系的な情報を提供しています。

第1章 イントロダクション

第2章 市場区分

第3章 市場概要

• 促進要因
• 抑制要因
• 機会
• 課題

第4章 重要考察

第5章 規制

• 概要
• 規制手続き

第6章 償還

• 概要
• 償還シナリオ

第7章 エグゼクティブサマリー

第8章 世界の止血剤市場：種類別

• 概要
• トロンビン
• 併用止血剤
• 酸化再生セルロース
• ゼラチン
• コラーゲン

第9章 世界の止血剤市場：用途別

• 概要
• 創傷閉鎖
• 外科用止血剤

第10章 世界の止血剤市場：流通経路別

• 概要

第11章 世界の止血剤市場：エンドユーザー別

• 概要
• 病院
• ASC
• 地域医療
• クリニック

第12章 世界の止血剤市場：地域別

• 概要
• 北米
• 欧州
• アジア太平洋地域
• 南米
• 中東・アフリカ

第13章 世界の止血剤市場：企業情勢

• 企業シェア分析：世界
• 企業シェア分析：北米
• 企業シェア分析：欧州
• 企業シェア分析：アジア太平洋地域

第14章 企業プロファイル

• ETHICON US, LLC
• PFIZER
• C.R BARD
• BAXTER
• VASCULAR SOLUTIONS, INC
• B.BRAUN MELSUNGEN AG
• 3-D MATRIX LTD
• RESORBA MEDICAL GMBH
• ANIKA THERAPEUTICS, INC.
• BIOM'UP
• CRYOLIFE, INC.
• EQUIMEDICAL
• HEMOSTASIS, LLC
• MEDTRADE PRODUCTS LIMITED
• STRYKER
• ARCH THERAPEUTICS, INC.
• INTEGRA LIFESCIENCES CORPORATION
• ALTAYLAR MEDICAL
• BIOCER ENTWICKLUNGS-GMBH
• SMI (STARCH MEDICAL)

第15章 関連レポート

The Global Hemostats Market is accounted to reach USD 4.5 billion by 2024 from USD 2.7 billion in 2016, at a CAGR of 6.6% in the forecast period 2017 to 2024.

The major factors driving the growth of this market are the increasing number of surgeries, increasing healthcare expenditure, technological advancements, chronic condition and aging population.

The key market players for Global Medical Aesthetics Market are listed below:

Ethicon US LLC (U.S.)

Pfizer and C.R. Bard Inc.,

Baxter,

Vascular Solutions, Inc.,

B.Braun Melsungen,

3-D Matrix, Ltd.,

Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company)

, Anika Therapeutics, Inc.,

Arch Therapeutics Inc.

, Biom'Up SAS,

CryoLife, Inc.,

Gamma Therapeutics, Inc.,

Hemostasis,

LLC,

MedTrade Products Limited,

Integra LifeSciences Corporation,

Medline Industries, Inc.,

HEMOTEC MEDICAL GMBH, Stryker,

CSL Behring,

Mallinckrodt,

Equimedical, B.V.

The market is further segmented into:

Type

Application

Usage Pattern

Mode Administration

End User

Geography

The Global Hemostats Market is segmented on the basis of type, application, distribution channel, and end user. The global hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based hemostats, gelatin based hemostats and collagen based hemostats. In 2017, the thrombin based hemostats segment is expected to dominate the market with a share of ~38.0% and collagen agents is expected to grow with the highest CAGR during the forecast period from 2017 to 2024.

Based on application, the market is segmented into surgery and wound closure.

Based on end users, the market is classified into hospitals, community healthcare, ambulatory centers and clinics. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.

Based on geography, the Global Medical Aesthetics market is segmented into 11 geographical regions, such as,

Japan,

North America,

South America,

Europe,

Asia-Pacific,

Middle East

Africa

Covered in this report

The report covers the present scenario and the growth prospects of the Global Medical Aesthetics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

TABLE OF CONTENTS

TABLE OF CONTENTS :

1. INTRODUCTION

• 1.1. OBJECTIVES OF THE STUDY
• 1.2. MARKET DEFINITION
• 1.3. OVERVIEW OF GLOBAL HEMOSTATS MARKET
• 1.4. CURRENCY AND PRICING
• 1.5. LIMITATION
• 1.6. MARKETS COVERED

2. MARKET SEGMENTATION

• 2.1. MARKETS COVERED
• 2.2. GEOGRAPHIC SCOPE
• 2.3. YEARS CONSIDERED FOR THE STUDY
• 2.4. CURRENCY AND PRICING
• 2.5. RESEARCH METHODOLOGY
• 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
• 2.7. SECONDARY SOURCE
• 2.8. ASSUMPTIONS

3. MARKET OVERVIEW

• 3.1. DRIVERS
  • 3.1.1. CHRONIC CONDITIONS AND AGING POPULATION LEADING TO INCREASE IN NUMBER OF SURGICAL PROCEDURES
  • 3.1.2. TECHNOLOGICAL ADVANCEMENTS
  • 3.1.3. INCREASING NUMBER OF MINIMALLY INVASIVE SURGERIES
  • 3.1.4. IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING HEALTHCARE SPENDING
• 3.2. RESTRAINTS
  • 3.2.1. RELUCTANCE OF SURGEONS TOWARDS NEW PRODUCTS
  • 3.2.2. WEAK REIMBURSEMENT
• 3.3. OPPORTUNITIES
  • 3.3.1. UNMET MEDICAL NEEDS
  • 3.3.2. EMERGING MARKET
• 3.4. CHALLENGES
  • 3.4.1. DEVELOPMENT OF SUBSTITUTE PRODUCTS
  • 3.4.2. LIMITATIONS OF HEMOSTATIC AGENTS IN ACHIEVING HEMOSTASIS

4. PREMIUM INSIGHTS

5. REGULATORY

• 5.1. OVERVIEW
• 5.2. REGULATORY PROCEDURE

6. REIMBURSEMENT

• 6.1. OVERVIEW
• 6.2. REIMBURSEMENT SCENARIO

7. EXECUTIVE SUMMARY

8. GLOBAL HEMOSTATS MARKET, BY TYPE

• 8.1. OVERVIEW
• 8.2. THROMBIN BASED HEMOSTATS
• 8.3. COMBINATION AGENT HEMOSTATS
• 8.4. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS
• 8.5. GELATIN BASED HEMOSTATS
• 8.6. COLLAGEN BASED HEMOSTATS

9. GLOBAL HEMOSTATS MARKET,BY APPLICATION

• 9.1. OVERVIEW
• 9.2. GLOBAL HEMOSTATS MARKET, BY APPLICATION
• 9.3. WOUND CLOSURE
• 9.4. SURGICAL HEMOSTATS

10. GLOBAL HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL

• 10.1. OVERVIEW
  • 10.1.1. DIRECT TENDERS
  • 10.1.2. RETAIL

11. GLOBAL HEMOSTATS MARKET, BY END USER

• 11.1. OVERVIEW
• 11.2. HOSPITALS
• 11.3. AMBULATORY CENTERS
• 11.4. COMMUNITY HEALTHCARE
• 11.5. CLINICS

12. GLOBAL HEMOSTATS MARKET, BY GEOGRAPHY

• 12.1. OVERVIEW
• 12.2. NORTH AMERICA
  • 12.2.1. U.S.
  • 12.2.2. CANADA
  • 12.2.3. MEXICO
• 12.3. EUROPE
  • 12.3.1. GERMANY
  • 12.3.2. FRANCE
  • 12.3.3. U.K.
  • 12.3.4. ITALY
  • 12.3.5. SPAIN
  • 12.3.6. RUSSIA
  • 12.3.7. TURKEY
  • 12.3.8. BELGIUM
  • 12.3.9. NETHERLANDS
  • 12.3.10. SWITZERLAND
  • 12.3.11. REST OF EUROPE
• 12.4. ASIA-PACIFIC (APAC)
  • 12.4.1. JAPAN
  • 12.4.2. CHINA
  • 12.4.3. SOUTH KOREA
  • 12.4.4. INDIA
  • 12.4.5. AUSTRALIA
  • 12.4.6. SINGAPORE
  • 12.4.7. THAILAND
  • 12.4.8. MALAYSIA
  • 12.4.9. INDONESIA
  • 12.4.10. PHILIPPINES
  • 12.4.11. REST OF APAC
• 12.5. SOUTH AMERICA
  • 12.5.1. BRAZIL
  • 12.5.2. REST OF SOUTH AMERICA
• 12.6. MEA
  • 12.6.1. SOUTH AFRICA
  • 12.6.2. REST OF MEA

13. GLOBAL HEMOSTATS MARKET, COMPANY LANDSCAPE

• 13.1. COMPANY SHARE ANALYSIS: GLOBAL
• 13.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
• 13.3. COMPANY SHARE ANALYSIS: EUROPE
• 13.4. COMPANY SHARE ANALYSIS: APAC

14. COMPANY PROFILES

• 14.1. ETHICON US, LLC (SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC)
  • 14.1.1. COMPANY OVERVIEW
  • 14.1.2. REVENUE ANALYSIS
  • 14.1.3. PRODUCT PORTFOLIO
  • 14.1.4. RECENT DEVELOPMENTS
• 14.2. PFIZER
  • 14.2.1. COMPANY OVERVIEW
  • 14.2.2. REVENUE ANALYSIS
  • 14.2.3. PRODUCT PORTFOLIO
  • 14.2.4. RECENT DEVELOPMENTS
• 14.3. C.R BARD
  • 14.3.1. COMPANY OVERVIEW
  • 14.3.2. REVENUE ANALYSIS
  • 14.3.3. PRODUCT PORTFOLIO
  • 14.3.4. RECENT DEVELOPMENTS
• 14.4. BAXTER
  • 14.4.1. COMPANY OVERVIEW
  • 14.4.2. REVENUE ANALYSIS
  • 14.4.3. PRODUCT PORTFOLIO
  • 14.4.4. RECENT DEVELOPMENTS
• 14.5. VASCULAR SOLUTIONS, INC (ACQUIRED BY TELEFLEX INCORPORATED)
  • 14.5.1. COMPANY OVERVIEW
  • 14.5.2. REVENUE ANALYSIS
  • 14.5.3. PRODUCT PORTFOLIO
  • 14.5.4. RECENT DEVELOPMENTS
• 14.6. B.BRAUN MELSUNGEN AG
  • 14.6.1. COMPANY OVERVIEW
  • 14.6.2. REVENUE ANALYSIS
  • 14.6.3. PRODUCT PORTFOLIO
  • 14.6.4. RECENT DEVELOPMENTS
• 14.7. 3-D MATRIX LTD
  • 14.7.1. COMPANY OVERVIEW
  • 14.7.2. REVENUE ANALYSIS
  • 14.7.3. PRODUCT PORTFOLIO
  • 14.7.4. RECENT DEVELOPMENTS
• 14.8. RESORBA MEDICAL GMBH
  • 14.8.1. COMPANY OVERVIEW
  • 14.8.2. REVENUE ANALYSIS
  • 14.8.3. PRODUCT PORTFOLIO
  • 14.8.4. RECENT DEVELOPMENTS
• 14.9. ANIKA THERAPEUTICS, INC.
  • 14.9.1. COMPANY OVERVIEW
  • 14.9.2. REVENUE ANALYSIS
  • 14.9.3. PRODUCT PORTFOLIO
  • 14.9.4. RECENT DEVELOPMENTS
• 14.10. BIOM'UP
  • 14.10.1. COMPANY OVERVIEW
  • 14.10.2. REVENUE ANALYSIS
  • 14.10.3. PRODUCT PORTFOLIO
  • 14.10.4. RECENT DEVELOPMENTS
• 14.11. CRYOLIFE, INC.
  • 14.11.1. COMPANY OVERVIEW
  • 14.11.2. REVENUE ANALYSIS
  • 14.11.3. PRODUCT PORTFOLIO
  • 14.11.4. RECENT DEVELOPMENTS
• 14.12. EQUIMEDICAL
  • 14.12.1. COMPANY OVERVIEW
  • 14.12.2. REVENUE ANALYSIS
  • 14.12.3. PRODUCT PORTFOLIO
  • 14.12.4. RECENT DEVELOPMENTS
• 14.13. HEMOSTASIS, LLC
  • 14.13.1. COMPANY OVERVIEW
  • 14.13.2. REVENUE ANALYSIS
  • 14.13.3. PRODUCT PORTFOLIO
  • 14.13.4. RECENT DEVELOPMENTS
• 14.14. MEDTRADE PRODUCTS LIMITED
  • 14.14.1. COMPANY OVERVIEW
  • 14.14.2. REVENUE ANALYSIS
  • 14.14.3. PRODUCT PORTFOLIO
  • 14.14.4. RECENT DEVELOPMENTS
• 14.15. STRYKER
  • 14.15.1. COMPANY OVERVIEW
  • 14.15.2. REVENUE ANALYSIS
  • 14.15.3. PRODUCT PORTFOLIO
  • 14.15.4. RECENT DEVELOPMENTS
• 14.16. ARCH THERAPEUTICS, INC.
  • 14.16.1. COMPANY OVERVIEW
  • 14.16.2. REVENUE ANALYSIS
  • 14.16.3. PRODUCT PORTFOLIO
  • 14.16.4. RECENT DEVELOPMENTS
• 14.17. INTEGRA LIFESCIENCES CORPORATION
  • 14.17.1. COMPANY OVERVIEW
  • 14.17.2. REVENUE ANALYSIS
  • 14.17.3. PRODUCT PORTFOLIO
  • 14.17.4. RECENT DEVELOPMENTS
• 14.18. ALTAYLAR MEDICAL
  • 14.18.1. COMPANY OVERVIEW
  • 14.18.2. REVENUE ANALYSIS
  • 14.18.3. PRODUCT PORTFOLIO
  • 14.18.4. RECENT DEVELOPMENTS
• 14.19. BIOCER ENTWICKLUNGS-GMBH
  • 14.19.1. COMPANY OVERVIEW
  • 14.19.2. REVENUE ANALYSIS
  • 14.19.3. PRODUCT PORTFOLIO
  • 14.19.4. RECENT DEVELOPMENTS
• 14.20. SMI (STARCH MEDICAL)
  • 14.20.1. COMPANY OVERVIEW
  • 14.20.2. REVENUE ANALYSIS
  • 14.20.3. PRODUCT PORTFOLIO
  • 14.20.4. RECENT DEVELOPMENTS

15. RELATED REPORTS

LIST OF TABLES

LIST OF TABLE :

TABLE 1 HEALTHCARE EXPENDITURES OF VARIOUS COUNTRIES

TABLE 2 ABSORBABLE HEMOSTATIC AGENTS APPROVED THROUGH PMA OR NDA*

TABLE 3 GLOBAL HEMOSTATS MARKET, BY PRODUCT TYPE, BY REGION 2015- 2024 (USD MILLION)

TABLE 4 GLOBAL HEMOSTATS MARKET, BY TYPE, 2015 - 2024(USD MILLION)

TABLE 5 GLOBAL HEMOSTATS MARKET, THROMBIN BASED, BY REGION 2015- 2024 (USD MILLION)

TABLE 6 GLOBAL HEMOSTATS MARKET, COMBINATION AGENT, BY REGION 2015- 2024 (USD MILLION)

TABLE 7 GLOBAL HEMOSTATS MARKET, OXIDIZED REGENERATED CELLULOSE BASED, BY REGION, 2015- 2024 (USD MILLION)

TABLE 8 GLOBAL HEMOSTATS MARKET, GELATIN BASED, BY REGION 2015- 2024 (USD MILLION)

TABLE 9 GLOBAL HEMOSTATS MARKET, COLLAGEN BASED, BY REGION 2015- 2024 (USD MILLION)

TABLE 10 GLOBAL HEMOSTATS APPLICATION MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 11 WOUND CLOSURE, BY APPLICATION, BY REGION, 2015 - 2024 (USD MILLION)

TABLE 12 SURGICAL HEMOSTATS, BY APPLICATION, BY REGION, 2015 - 2024 (USD MILLION)

TABLE 13 GLOBAL HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 14 GLOBAL HEMOSTATS MARKET, DIRECT TENDERS, BY REGION, 2015 - 2024 (USD MILLION)

TABLE 15 GLOBAL HEMOSTATS MARKET, RETAIL, BY REGION, 2015 - 2024 (USD MILLION)

TABLE 16 GLOBAL HEMOSTATS MARKET, BY END USER, 2015- 2024 (USD MILLION)

TABLE 17 GLOBAL HEMOSTATS MARKET, HOSPITALS, BY REGION 2015- 2024 (USD MILLION)

TABLE 18 GLOBAL HEMOSTATS MARKET, AMBULATORY CENTERS, BY REGION 2015- 2024 (USD MILLION)

TABLE 19 GLOBAL HEMOSTATS MARKET, COMMUNITY HEALTHCARE, BY REGION 2015- 2024 (USD MILLION)

TABLE 20 GLOBAL HEMOSTATS MARKET, CLINICS, BY REGION 2015- 2024 (USD MILLION)

TABLE 21 GLOBAL HEMOSTATS MARKET, BY GEOGRAPHY, 2015 - 2024 (USD MILLION)

TABLE 22 NORTH AMERICA HEMOSTATSMARKET, BY COUNTRY, 2015 - 2024 (USD MILLION)

TABLE 23 NORTH AMERICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 24 NORTH AMERICA HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 25 NORTH AMERICA HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 26 NORTH AMERICA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 27 U.S. HEMOSTATS MARKET, BY PRODUCT TYPE ,2015 - 2024 (USD MILLION)

TABLE 28 U.S. HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 29 U.S.HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 30 U.S. HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 31 CANADA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 32 CANADA HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 33 CANADA HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 34 CANADA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 35 MEXICO HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024(USD MILLION)

TABLE 36 MEXICO HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 37 MEXICO HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 38 MEXICO HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 39 EUROPE HEMOSTATS S MARKET, BY COUNTRY, 2015 - 2024 (USD MILLION)

TABLE 40 EUROPEHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024(USD MILLION)

TABLE 41 EUROPE HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 42 EUROPE HEMOSTATS MARKET, BY END USER,2015 - 2024 (USD MILLION)

TABLE 43 EUROPE HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 44 GERMANYHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024(USD MILLION)

TABLE 45 GERMANY HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 46 GERMANY HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 47 GERMANY HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 48 FRANCE HEMOSTATS MARKET, BY PRODUCT TYPE,2015 - 2024(USD MILLION)

TABLE 49 FRANCE HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 50 FRANCE HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 51 FRANCE HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 52 U.K. HEMOSTATS MARKET, BY PRODUCT TYPE,2015 - 2024(USD MILLION)

TABLE 53 U.K. HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 54 U.K. HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 55 U.K. HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 56 ITALY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 57 ITALY HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 58 ITALY HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 59 ITALY HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 60 SPAIN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 61 SPAIN HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 62 SPAIN HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 63 SPAIN HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 64 RUSSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 65 RUSSIA HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 66 RUSSIA HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 67 RUSSIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 68 TURKEY HEMOSTATS MARKET, BY PRODUCT TYPE,2015 - 2024(USD MILLION)

TABLE 69 TURKEY HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 70 TURKEY HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 71 TURKEY HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 72 BELGIUM HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 73 BELGIUM HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 74 BELGIUM HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 75 BELGIUM HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 76 NETHERLANDS HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 77 NETHERLANDS HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 78 NETHERLANDS HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 79 NETHERLANDS HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 80 SWITZERLAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 81 SWITZERLAND HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 82 SWITZERLAND HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 83 SWITZERLAND HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 84 REST OF EUROPE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 85 APAC HEMOSTATS S MARKET, BY COUNTRY, 2015 - 2024 (USD MILLION)

TABLE 86 APAC HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 87 APAC HEMOSTATS MARKET, BY APPLICATION,2015 - 2024 (USD MILLION)

TABLE 88 APAC HEMOSTATS MARKET, BY END USER,2015 - 2024 (USD MILLION)

TABLE 89 APAC HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 90 JAPAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 91 JAPAN HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 92 JAPAN HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 93 JAPAN HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 94 CHINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 95 CHINA HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 96 CHINA HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 97 CHINA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 98 SOUTH KOREAHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024(USD MILLION)

TABLE 99 SOUTH KOREA HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 100 SOUTH KOREA HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 101 SOUTH KOREA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 102 INDIA HEMOSTATS MARKET, BY PRODUCT TYPE,2015 - 2024(USD MILLION)

TABLE 103 INDIA HEMOSTATS MARKET, BY APPLICATION,2015 - 2024 (USD MILLION)

TABLE 104 INDIA HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 105 INDIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 106 AUSTRALIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 107 AUSTRALIA HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 108 AUSTRALIA HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 109 AUSTRALIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 110 SINGAPORE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 111 SINGAPORE HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 112 SINGAPORE HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 113 SINGAPORE HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 114 THAILAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 115 THAILAND HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 116 THAILAND HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 117 THAILAND HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 118 MALAYSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 119 MALAYSIA HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 120 MALAYSIA HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 121 MALAYSIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 122 INDONESIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 123 INDONESIA HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 124 INDONESIA HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 125 INDONESIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 126 PHILIPPINES HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 127 PHILIPPINES HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 128 PHILIPPINES HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 129 PHILIPPINES HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 130 REST OF APACHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024(USD MILLION)

TABLE 131 SOUTH AMERICAHEMOSTATS S MARKET, BY COUNTRY, 2015 - 2024 (USD MILLION)

TABLE 132 SOUTH AMERICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 133 SOUTH AMERICA HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 134 SOUTH AMERICA HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 135 SOUTH AMERICA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 136 BRAZIL HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 137 BRAZIL HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 138 BRAZIL HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 139 BRAZIL HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 140 REST OF SOUTH AMERICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 141 MEA HEMOSTATS MARKET, BY COUNTRY, 2015 - 2024 (USD MILLION)

TABLE 142 MEA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 143 MEA HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 144 MEA HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 145 MEA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 146 SOUTH AFRICAHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

TABLE 147 SOUTH AFRICA HEMOSTATS MARKET, BY APPLICATION, 2015 - 2024 (USD MILLION)

TABLE 148 SOUTH AFRICA HEMOSTATS MARKET, BY END USER, 2015 - 2024 (USD MILLION)

TABLE 149 SOUTH AFRICA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 - 2024 (USD MILLION)

TABLE 150 REST OF MEA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 - 2024 (USD MILLION)

LIST OF FIGURES

LIST OF FIGURES

FIGURE 1 GLOBAL HEMOSTATS MARKET: SEGMENTATION

FIGURE 2 GLOBAL HEMOSTATS MARKET: GEOGRAPHIC SCOPE

FIGURE 3 GLOBAL HEMOSTATS MARKET: DATA TRIANGULATION

FIGURE 4 GLOBAL HEMOSTATS MARKET RESEARCH SNAPSHOT

FIGURE 5 GLOBAL HEMOSTATS MARKET BOTTOM UP APPROACH

FIGURE 6 GLOBAL HEMOSTATS MARKET TOP DOWN APPROACH

FIGURE 7 GLOBAL HEMOSTATS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 MEDICAL ADVANCEMENTS AND INCREASE IN HEMORRAGE CASES ARE EXPECTED TO DRIVE THE MARKET FOR HEMOSTATS IN THE FORECAST PERIOD 2017 TO 2024

FIGURE 9 THROMBIN BASED HEMOSTATS MARKET SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE HEMOSTATS MARKET IN 2017 & 2024

FIGURE 10 ASIA PACIFIC IS THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR HEMOSTATS MANUFACTURERS IN THE FORECAST PERIOD TO 2024

FIGURE 11 GLOBAL HEMOSTATS MARKET: SEGMENTATION

FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE MARKET FOR HEMOSTATS AND APAC IS EXPECTED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD TO 2024

FIGURE 13 GLOBAL HEMOSTATS MARKET: BY TYPE, SNAPSHOT 2016

FIGURE 14 GLOBAL THROMBIN BASED HEMOSTATS MARKET: BY REGION

FIGURE 15 GLOBAL COMBINATION AGENT HEMOSTATS MARKET: BY REGION

FIGURE 16 GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET: BY REGION

FIGURE 17 GLOBAL GELATIN BASED HEMOSTATS MARKET: BY REGION

FIGURE 18 GLOBAL COLLAGEN BASED HEMOSTATS MARKET: BY REGION

FIGURE 19 GLOBAL HEMOSTATS MARKET: BY APPLICATION, SNAPSHOT 2016

FIGURE 20 GLOBAL HEMOSTATS MARKET: WOUND CLOSURE, BY REGION

FIGURE 21 GLOBAL HEMOSTATS MARKET: SURGERIES, BY REGION

FIGURE 22 GLOBAL HEMOSTATS MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016

FIGURE 23 GLOBAL HEMOSTATS MARKET: DIRECT TENDERS, BY REGION

FIGURE 24 GLOBAL HEMOSTATS MARKET: RETAIL, BY REGION

FIGURE 25 GLOBAL HEMOSTATS MARKET DOMINATED BY HOSPITALS

FIGURE 26 GLOBAL HEMOSTATS MARKET:BY END-USER, SNAPSHOT 2016

FIGURE 27 GLOBAL HEMOSTATS MARKET: HOSPITALS; BY REGION

FIGURE 28 GLOBAL HEMOSTATS MARKET: AMBULATORY CENTERS; BY REGION

FIGURE 29 GLOBAL HEMOSTATS MARKET: COMMUNITY HEALTHCARE; BY REGION

FIGURE 30 GLOBAL HEMOSTATS MARKET: CLINICS; BY REGION

FIGURE 31 GLOBAL HEMOSTATS MARKET SNAPSHOT (2017)

FIGURE 32 GLOBAL HEMOSTATS MARKET: BY GEOGRAPHY (2016)

FIGURE 33 GLOBAL HEMOSTATS MARKET :BY COUNTRY (2017)

FIGURE 34 GLOBAL HEMOSTATS MARKET BY COUNTRY (2016 & 2024)

FIGURE 35 GLOBAL HEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024)

FIGURE 36 NORTH AMERICA HEMOSTATS MARKET SNAPSHOT (2017)

FIGURE 37 NORTH AMERICA HEMOSTATS MARKET: BY GEOGRAPHY (2016)

FIGURE 38 NORTH AMERICA HEMOSTATSMARKET :BY COUNTRY (2017)

FIGURE 39 NORTH AMERICA HEMOSTATS MARKET BY COUNTRY (2016 & 2024)

FIGURE 40 NORTH AMERICA HEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024

FIGURE 41 EUROPE HEMOSTATS MARKET SNAPSHOT (2017)

FIGURE 42 EUROPE HEMOSTATS MARKET: BY GEOGRAPHY (2016)

FIGURE 43 EUROPE HEMOSTATS MARKET :BY COUNTRY (2017)

FIGURE 44 EUROPE HEMOSTATS MARKET BY COUNTRY (2016 & 2024)

FIGURE 45 EUROPE HEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024)

FIGURE 46 APAC HEMOSTATS MARKET SNAPSHOT (2017)

FIGURE 47 APAC HEMOSTATS MARKET: BY GEOGRAPHY (2016)

FIGURE 48 APAC HEMOSTATS MARKET :BY COUNTRY (2017)

FIGURE 49 APAC HEMOSTATS MARKET BY COUNTRY (2016 & 2024)

FIGURE 50 APAC HEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024)

FIGURE 51 SOUTH AMERICAHEMOSTATS MARKET SNAPSHOT (2017)

FIGURE 52 SOUTH AMERICA HEMOSTATS MARKET: BY GEOGRAPHY (2016)

FIGURE 53 SOUTH AMERICA HEMOSTATS MARKET :BY COUNTRY (2017)

FIGURE 54 SOUTH AMERICAHEMOSTATS MARKET BY COUNTRY (2016 & 2024)

FIGURE 55 SOUTH AMERICAHEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024)

FIGURE 56 MEA HEMOSTATS MARKET SNAPSHOT (2017)

FIGURE 57 MEA HEMOSTATS MARKET: BY GEOGRAPHY (2016)

FIGURE 58 MEA HEMOSTATS MARKET :BY COUNTRY (2017)

FIGURE 59 MEA HEMOSTATS MARKET BY COUNTRY (2016 & 2024)

FIGURE 60 MEA HEMOSTATS MARKET BY PRODUCT TYPE (2017 & 2024)

FIGURE 61 GLOBAL HEMOSTATS MARKET: COMPANY SHARE 2016 (%)

FIGURE 62 NORTH AMERICA HEMOSTATS MARKET: COMPANY SHARE 2016 (%)

FIGURE 63 EUROPE HEMOSTATS MARKET: COMPANY SHARE 2016 (%)

FIGURE 64 APAC HEMOSTATS MARKET: COMPANY SHARE 2016 (%)